Holen Sie sich die Stockscreener-App
15.60
1.52%
-0.22
Schlusskurs vom Vortag:
$15.82
Offen:
$15.78
24-Stunden-Volumen:
487.42K
Relative Volume:
1.22
Marktkapitalisierung:
$633.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-168.05M
KGV:
-3.0409
EPS:
-5.13
Netto-Cashflow:
$-146.15M
1W Leistung:
-1.08%
1M Leistung:
+2.43%
6M Leistung:
+63.14%
1J Leistung:
-73.94%
1-Tages-Spanne:
$15.43
$15.96
1-Wochen-Bereich:
$15.43
$16.30
52-Wochen-Spanne:
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
Firmenname
Keros Therapeutics Inc
Sektor
Branche
Telefon
617-314-6297
Adresse
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Vergleichen Sie KROS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.59 | 642.54M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.93 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.58 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.79 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
777.48 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-01-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-16 | Bestätigt | Oppenheimer | Outperform |
| 2024-12-13 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-12 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | Eingeleitet | Jefferies | Buy |
| 2024-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-23 | Eingeleitet | Guggenheim | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-02-21 | Eingeleitet | William Blair | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | Wedbush | Outperform |
| 2023-07-26 | Eingeleitet | BofA Securities | Buy |
| 2023-02-14 | Eingeleitet | Cowen | Outperform |
| 2022-10-18 | Eingeleitet | Truist | Buy |
| 2022-07-26 | Eingeleitet | BTIG Research | Buy |
| 2020-12-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-04 | Eingeleitet | Jefferies | Buy |
| 2020-05-04 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Keros Therapeutics Inc Aktie (KROS) Neueste Nachrichten
Can Keros Therapeutics Inc. recover in the next quarterMarket Performance Summary & Verified Technical Signals - newser.com
Keros Therapeutics Inc Stock Analysis and ForecastMarket Profile Overview & Double Digit Returns - earlytimes.in
What analysts say about Keros Therapeutics Inc stockInsider Selling Patterns & Affordable Trading Plans - earlytimes.in
Is Peeti Securities Limited Positioned to Benefit From Geographic ExpansionSector Performance Review & Achieve Triple Digit Returns - earlytimes.in
Is Keros Therapeutics Inc. stock poised for growthDollar Strength & Fast Entry High Yield Stock Tips - newser.com
How to interpret RSI for Keros Therapeutics Inc. stockJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
Will Keros Therapeutics Inc. bounce back from current support2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com
Quantitative breakdown of Keros Therapeutics Inc. recent moveJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
What momentum indicators show for Keros Therapeutics Inc. stock2025 Analyst Calls & Trade Opportunity Analysis Reports - newser.com
Can machine learning forecast Keros Therapeutics Inc. recoveryWeekly Loss Report & Reliable Entry Point Trade Alerts - newser.com
Is Keros Therapeutics Inc a good long term investmentEconomic Indicators Overview & Affordable Market Investment - earlytimes.in
What drives Keros Therapeutics Inc stock priceContrarian Investment Ideas & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting - ADVFN
Keros Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha
TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is now a turning point for Keros Therapeutics Inc.Watch List & Reliable Price Breakout Alerts - newser.com
CEO Change: Whats next for National Storage Affiliates Trust stockMarket Trend Report & Weekly High Potential Stock Alerts - خودرو بانک
Layoff Watch: Is Liberty Global Ltd stock risky to hold now2025 Investor Takeaways & Entry and Exit Point Strategies - خودرو بانک
Acadian Asset Management LLC Invests $1.50 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
Goldman Sachs Group Inc. Buys 205,022 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
What indicators show strength in Keros Therapeutics Inc.July 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
Insider Sell: Is Fifth Third Bancorp a defensive stockWeekly Market Summary & Real-Time Stock Entry Alerts - khodrobank.com
IPO Launch: Is Keros Therapeutics Inc. stock trending bullishTrade Risk Summary & Accurate Buy Signal Alerts - khodrobank.com
Can Keros Therapeutics Inc. rally from current levelsWeekly Trade Summary & AI Enhanced Market Trend Forecasts - newser.com
Quarterly Risk: Will Keros Therapeutics Inc. benefit from rising consumer demandJuly 2025 Momentum & AI Optimized Trade Strategies - خودرو بانک
Buybacks Report: Is WF International Limited stock forming a triangle patternJuly 2025 Action & Fast Entry High Yield Tips - khodrobank.com
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Trend Recap: Can BOWN expand into new marketsRate Hike & Expert Approved Momentum Trade Ideas - khodrobank.com
How to use Fibonacci retracement on Keros Therapeutics Inc.Quarterly Trade Report & Trade Opportunity Analysis Reports - newser.com
Is Keros Therapeutics Inc. stock trending bullishQuarterly Portfolio Review & Weekly High Return Forecasts - خودرو بانک
Aug Sentiment: Will Range Resources Corporation benefit from government policyInsider Buying & Expert Approved Momentum Ideas - خودرو بانک
Resistance Check: Is Keros Therapeutics Inc. stock good for income investorsWeekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
H.C. Wainwright Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
Buyout Rumor: What is the target price for Keros Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - خودرو بانک
Acadian Asset Management LLC Takes Position in Keros Therapeutics, Inc. $KROS - Defense World
Whale Trades: Should you buy the dip on Lobo EV Technologies Ltd2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
Stock Market Recap: Can Keros Therapeutics Inc weather a recessionJuly 2025 Sentiment & Low Risk High Reward Ideas - خودرو بانک
Aug Retail: Is Keros Therapeutics Inc. on track to beat earningsJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - khodrobank.com
Buyout Rumor: What is the next catalyst for ACCSQuarterly Market Summary & AI Powered Buy/Sell Recommendations - خودرو بانک
Sarcopenia Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | TNF Pharma, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross - Barchart.com
Momentum Shift: Whats the fair value of Keros Therapeutics Inc stockMarket Growth Review & Low Drawdown Investment Strategies - خودرو بانک
New Highs: Does Keros Therapeutics Inc stock reflect fundamentals2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
Volume Summary: What is the next catalyst for Keros Therapeutics IncMarket Growth Report & Risk Controlled Daily Plans - khodrobank.com
Quarterly Earnings: Is RMSGW stock showing strong momentumJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - خودرو بانک
Gap Down: How does Keros Therapeutics Inc. correlate with NasdaqWeekly Trade Review & Low Risk Profit Maximizing Plans - خودرو بانک
Market Overview: Is Spirit AeroSystems Holdings Inc affected by consumer sentiment2025 Pullback Review & Weekly Chart Analysis and Trade Guides - خودرو بانک
Exit Recap: What is HCWB s revenue forecastGap Down & Community Verified Trade Signals - خودرو بانک
Buyout Rumor: Is Keros Therapeutics Inc. backed by strong institutional buying2025 Analyst Calls & Verified Trade Idea Suggestions - خودرو بانک
Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):